Voiding function following prolapse surgery. Impact of estrogen replacement.
OBJECTIVE
To identify factors that would predict postoperative bladder function in postmenopausal women undergoing pelvic reconstructive surgery for pelvic organ prolapse.


METHODS
Demographic variables and urodynamic measures were analyzed in respect to the length of postoperative bladder catheterization.


RESULTS
Patient age, the presence of abnormal preoperative voiding patterns or elevated postvoid residuals, the route of surgical approach and the performance of urethropexy did not correlate significantly with the length of postoperative catheterization; only hormonal status did. Postmenopausal women using estrogen replacement therapy required significantly fewer days of catheterization than those who were not receiving estrogen replacement therapy.


CONCLUSIONS
The use of preoperative estrogen replacement therapy is associated with a reduction in the length of postoperative bladder catheterization in women undergoing pelvic reconstructive surgery for pelvic organ prolapse.
Theofrastous
J P
JP
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
Addison
W A
WA
Timmons
M C
MC
D000368:Aged; D015914:Estrogen Replacement Therapy / Q000592:standards*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010388:Pelvis; D017698:Postmenopause / Q000502:physiology; D011182:Postoperative Care; D013997:Time Factors; D001743:Urinary Bladder / Q000187:drug effects / Q000502:physiology; D014546:Urinary Catheterization; D014554:Urination / Q000187:drug effects / Q000502:physiology*; D014596:Uterine Prolapse / Q000503:physiopathology / Q000601:surgery*